Abstract:AIM:To develop a novel non-sequencing method for the detection of hepatitis B virus (HBV) pre-S deletion mutants in HBV carriers. METHODS:The entire region of HBV pre-S1 and pre-S2 was amplified by polymerase chain reaction (PCR).The size of PCR products was subsequently determined by capillary gel electrophoresis (CGE).CGE were carried out in a PACE-MDQ instrument equipped with a UV detector set at 254 nm.The samples were separated in 50 μm ID eCAP Neutral Coated Capillaries using a voltage of 6 kV for 30 min.Data acquisition and analysis were performed using the 32 Karat Software.A total of 114 DNA clones containing different sizes of the HBV pre-S gene were used to determine the accuracy of the CGE method.One hundred and fifty seven hepatocellular carcinoma (HCC) and 160 non-HCC patients were recruited into the study to assess the association between HBV pre-S deletion and HCC by using the newly-established CGE method.Nine HCC cases with HBV pre-S deletion at the diagnosis year were selected to conduct a longitudinal observation using serial serum samples collected 2-9 years prior to HCC diagnosis.RESULTS: CGE allowed the separation of PCR products differing in size > 3 bp and was able to identify 10% of the deleted DNA in a background of wild-type DNA.The accuracy rate of CGE-based analysis was 99.1% compared with the clone sequencing results.Using this assay, pre-S deletion was more frequently found in HCC patients than in non-HCC controls (47.1% vs 28.1%, P < 0.001).Interestingly, the increased risk of HCC was mainly contributed by the short deletion of pre-S.While the deletion ≤ 99 bp was associated with a 2.971-fold increased risk of HCC (95%CI:1.723-5.122,P < 0.001), large deletion (> 99 bp) did not show any association with HCC (P = 0.918, OR = 0.966, 95%CI: 0.501-1.863).Of the 9 patients who carried pre-S deletions at the stage of HCC, 88.9% (8/9) had deletions 2-5 years prior to HCC, while only 44.4%4 (4/9) contained such deletions 6-9 years prior to HCC.CONCLUSION: CGE is a sensitive approach for HBV pre-S deletion analysis.Pre-S deletion, especially for short DNA fragment deletion, is a useful predictive marker for HCC.

Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta.

Quasispecies Pattern of Hepatitis B Virus Predicts Hepatocellular Carcinoma Using Deep-Sequencing and Machine Learning

Temporal Acquisition of Sequential Mutations in the Enhancer Ii and Basal Core Promoter of Hbv in Individuals at High Risk for Hepatocellular Carcinoma

Whole-Exome Sequencing-Based Mutational Profiling of Hepatitis B Virus-Related Early-Stage Hepatocellular Carcinoma

Hepatitis B Virus Genotype, Mutations, Human Leukocyte Antigen Polymorphisms and Their Interactions in Hepatocellular Carcinoma: A Multi-Centre Case-Control Study

Combined pre-S deletion and core promoter mutations related to hepatocellular carcinoma: A nested case-control study in China.

Genome-wide methylation profiling of the different stages of hepatitis B virus-related hepatocellular carcinoma development in plasma cell-free DNA reveals potential biomarkers for early detection and high-risk monitoring of hepatocellular carcinoma

Nucleotide variants in hepatitis B virus preS region predict the recurrence of hepatocellular carcinoma

Potential Susceptibility Mutations in C Gene for Hepatitis B-Related Hepatocellular Carcinoma Identified by a Two-Stage Study in Qidong, China

Evolutionary Analysis of Pre-S/S Mutations in HBeAg-Negative Chronic Hepatitis B with HBsAg < 100 IU/ml

Deep sequencing of HBV pre-S region reveals high heterogeneity of HBV genotypes and associations of word pattern frequencies with HCC.

Quasispecies characteristic in "a" determinant region is a potential predictor for the risk of immunoprophylaxis failure of mother-to-child-transmission of sub-genotype C2 hepatitis B virus: a prospective nested case-control study.

Effect of combined mutations in the enhancer II and basal core promoter of hepatitis B virus on development of hepatocellular carcinoma in Qidong, China.

Novel Approach to Identifying the Hepatitis B Virus Pre-S Deletions Associated with Hepatocellular Carcinoma

Sparse Logistic Regression Revealed the Associations Between HBV PreS Quasispecies and Hepatocellular Carcinoma.

Fine Mapping of the MHC Region Identifies Novel Variants Associated with HBV-Related Hepatocellular Carcinoma in Han Chinese

Full-length Genomic Analysis of Hepatitis B Virus Isolates in a Patient Progressing from Hepatitis to Hepatocellular Carcinoma.

Host and Viral Genetic Variation in HBV-Related Hepatocellular Carcinoma

Genetic Variations in Plasma Circulating DNA of HBV-Related Hepatocellular Carcinoma Patients Predict Recurrence after Liver Transplantation

Role of early on-treatment serum HBV RNA declines in predicting hepatocellular carcinoma risk in patients with chronic hepatitis B

The Impact of HBV Quasispecies Features on Immune Status in HBsAg+/HBsAb+ Patients With HBV Genotype C Using Next-Generation Sequencing